JAMES MAZGAJ: Open Payments
NPI 1912039108 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,359 in 42 payments from 8 companies in 2025. Trend: 2023 $1,167 · 2024 $881 · 2025 $1,359
Food & beverage: $1,359
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $447 |
| Janssen Pharmaceuticals, Inc | 4 | $218 |
| Alkermes, Inc. | 5 | $178 |
| E.R. Squibb & Sons, L.L.C. | 4 | $139 |
| Axsome Therapeutics, Inc. | 3 | $133 |
| Otsuka America Pharmaceutical, Inc. | 4 | $101 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $76 |
| Neurocrine BioSciences, Inc. | 3 | $67 |
Products named: VRAYLAR, INVEGA SUSTENNA, COBENFY, Auvelity, LYBALVI, CAPLYTA, ABILIFY ASIMTUFII, ARISTADA.
Industry payments across SC — which companies pay providers there.
